Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GRIK1 antisense RNA 3 (GRIK1-AS3)
- Target
- GRIK1-AS3
- Molecular classification
- Long non-coding RNA, Antisense RNA, Other (non-protein-coding RNA)
01
Overview
GRIK1 antisense RNA 3 (GRIK1-AS3) is a long non-coding RNA transcribed from the GRIK1 gene locus in humans. It does not encode a protein and is presumed to function as a regulatory RNA, potentially involved in modulating the expression of the GRIK1 gene (which encodes the Glutamate receptor, ionotropic, kainate 1 subunit). While other antisense RNAs transcribed from this region (such as GRIK1-AS1 and GRIK1-AS2) have been studied for their regulatory roles affecting neuronal function and disease, there are currently no specific studies defining the biological function, disease associations, or drug interactions of GRIK1-AS3. It is cataloged in several gene databases as a distinct RNA gene but is not currently considered a therapeutic target.
- Other names
- GRIK1-AS3GRIK1 antisense RNA 3
02
Biological functions
Unknown/direct evidence unavailableBy analogy to other GRIK1 antisense RNAs, such molecules may regulate gene expression of the sense GRIK1 transcript through mechanisms such as RNA interference, transcriptional modulation, or splicing effects (no direct evidence for GRIK1-AS3 itself was identified).
03
Disease associations
Other (no direct associations or validated disease roles currently reported for GRIK1-AS3 specifically; GRIK1 locus and other antisense transcripts are implicated in neuropsychiatric and neurological disorders, but evidence for GRIK1-AS3 was not found).
Beyond the preview
Go deeper on GRIK1 antisense RNA 3 (GRIK1-AS3).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on GRIK1 antisense RNA 3 (GRIK1-AS3).